Research ArticleArticle
Patient-reported Health-related Quality of Life with Apremilast for Psoriatic Arthritis: A Phase II, Randomized, Controlled Study
Vibeke Strand, Georg Schett, ChiaChi Hu and Randall M. Stevens
The Journal of Rheumatology April 2013, jrheum.121200; DOI: https://doi.org/10.3899/jrheum.121200
Vibeke Strand
From the Division of Immunology and Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; University Erlangen- Nuremberg, Erlangen, Germany; and Celgene Corporation, Summit, New Jersey, USA. Sponsored by Celgene Corporation. V. Strand, MD, Adjunct Clinical Professor, Division of Immunology and Rheumatology, Stanford University School of Medicine; G. Schett, MD, University Erlangen-Nuremberg; C. Hu, EdM, MS; R.M. Stevens, MD, Celgene Corporation. Address correspondence to Dr. V. Strand, Division of Immunology and Rheumatology, Stanford University School of Medicine, 306 Ramona Road, Portola Valley, CA 94028, USA. E-mail: vstrand@stanford.edu Accepted for publication February 4, 2013.
Georg Schett
From the Division of Immunology and Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; University Erlangen- Nuremberg, Erlangen, Germany; and Celgene Corporation, Summit, New Jersey, USA. Sponsored by Celgene Corporation. V. Strand, MD, Adjunct Clinical Professor, Division of Immunology and Rheumatology, Stanford University School of Medicine; G. Schett, MD, University Erlangen-Nuremberg; C. Hu, EdM, MS; R.M. Stevens, MD, Celgene Corporation. Address correspondence to Dr. V. Strand, Division of Immunology and Rheumatology, Stanford University School of Medicine, 306 Ramona Road, Portola Valley, CA 94028, USA. E-mail: vstrand@stanford.edu Accepted for publication February 4, 2013.
ChiaChi Hu
From the Division of Immunology and Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; University Erlangen- Nuremberg, Erlangen, Germany; and Celgene Corporation, Summit, New Jersey, USA. Sponsored by Celgene Corporation. V. Strand, MD, Adjunct Clinical Professor, Division of Immunology and Rheumatology, Stanford University School of Medicine; G. Schett, MD, University Erlangen-Nuremberg; C. Hu, EdM, MS; R.M. Stevens, MD, Celgene Corporation. Address correspondence to Dr. V. Strand, Division of Immunology and Rheumatology, Stanford University School of Medicine, 306 Ramona Road, Portola Valley, CA 94028, USA. E-mail: vstrand@stanford.edu Accepted for publication February 4, 2013.
Randall M. Stevens
From the Division of Immunology and Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; University Erlangen- Nuremberg, Erlangen, Germany; and Celgene Corporation, Summit, New Jersey, USA. Sponsored by Celgene Corporation. V. Strand, MD, Adjunct Clinical Professor, Division of Immunology and Rheumatology, Stanford University School of Medicine; G. Schett, MD, University Erlangen-Nuremberg; C. Hu, EdM, MS; R.M. Stevens, MD, Celgene Corporation. Address correspondence to Dr. V. Strand, Division of Immunology and Rheumatology, Stanford University School of Medicine, 306 Ramona Road, Portola Valley, CA 94028, USA. E-mail: vstrand@stanford.edu Accepted for publication February 4, 2013.
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 3
1 Mar 2024
Patient-reported Health-related Quality of Life with Apremilast for Psoriatic Arthritis: A Phase II, Randomized, Controlled Study
Vibeke Strand, Georg Schett, ChiaChi Hu, Randall M. Stevens
The Journal of Rheumatology Apr 2013, jrheum.121200; DOI: 10.3899/jrheum.121200